Open Call for a Post-Doctoral Research Fellowship
The Instituto Gulbenkian de Ciência (IGC) is welcoming applications to a Post-Doctoral ResearchFellowship (BI-PD), under the project LCF/PR/HR22/52420023, Project Proposal HR22-00799,
with the title “T cell acute lymphoblastic leukemia: Origin & Relapse (T-ALLOREL)”, financed
by Fundación Bancaria Caixa d’Estalvis i Pensions de Barcelona ("La Caixa" Foundation) withthe following conditions:
1. Duration The fellowship duration according to the IGC Research Fellowship Regulation
approved by FCT is 12 months, with the possibility of renewal up to a maximum limit of 3 years.
The fellowship contract is expected to start by June 2024, under the exclusiveness regime asrequired by Research Fellowship Regulation of Fundação para a Ciência e Tecnologia, IP (FCT).
2. Subject of Activities: T-ALLOREL proposes to study initiation and relapse in T cell acutelymphoblastic leukemia (T-ALL). T-ALL is a particularly aggressive blood-borne cancer thatarises from cells of the immune system: T lymphocytes. It affects mostly children but can also
affect adults. Although T-ALL can be currently cured in 80% of children and 60% of adultpatients, it causes severe secondary side effects. Furthermore, 20% of pediatric and 40% of adult
T-ALL cases where therapy fails, succumb to an uncontrollable disease. Improving therapy
requires further understanding of the causes that trigger T-ALL and how the disease re-emerges
in relapse. We propose an innovative approach to address this challenge to reveal how normal
cells become leukemic and how these resist treatment to allow the disease to re-emerge. We willaddress these aspects by integrating mouse and human cell work. T-ALLORREL should translate
into the development of novel therapies and strategies to distinguish responders from nonresponders, ensuring more effective therapy for the latter.
3. Scientific Areas: Immunology, Cancer, Mouse models.
4. Scientific Guidance: The selected candidate will join the laboratory of Lymphocyte
Development and Leukemogenesis (https://gulbenkian.pt/ciencia/research-groups/vmartins/),headed by Dr. Vera Martins.
5. Academic Profile and Admission Requirements: The candidate must hold a doctoral degreeand hold a degree in Biology, Biochemistry or related area. Previous expertise in flow cytometry
and the mouse as model organism are required; Fluency in English (written and spoken) isrequired.
Additionally, we will prefer candidates with background in Immunology, developmental biology,
or cancer using animal models.
According to point 3 of article 3º of the IGC Research Fellowship Regulation, the doctoral degree
must have been obtained in the three years prior to the date of submission of the fellowship
application.
If the qualification has been conferred by a foreign higher education institution it must berecognized by a Portuguese higher education institution, under the terms of the provisions ofarticle
25.ºofDecree-Law
n.º66/2018,ofAugust
16th(https://www.dges.gov.pt/en/pagina/degree-and-diploma-recognition), which approves the legal
regime of recognition of academic degrees and diplomas of Higher Education, attributed by
Financed by:foreign higher education institutions, and of paragraph e) of n.º 2 of article 4.º of Decree-Law n.º
60/2018, of August 3rd, and any formalities established therein must be fulfilled by the date of
the hiring act. The jury reserves the right to invite the candidate ranked immediately after to theposition in question when the first ranked candidate is not recognized with the academic degree
after the aforementioned formalities have been fulfilled.
6. For Portuguese taxpayers: All candidates that where/are currently taxpayers in Portugal arerequired to present evidence of the fulfillment of their individual obligations towards thePortuguese Tax Authority and Social Security. Failure to comply with this requirement will beconsidered as a criteria for exclusion from the recruitment process.
7. Applicable legislation and Regulation: All candidates must comply with the IGC Research
Fellowship Regulation; Research Fellowship Statutes amended by Decree nº 123/2019 of August
28th; FCT Legislation and Regulations for Fellowships and the Decree-Law n.º 66/2018, ofAugust 16th (Legal regime for recognition of academic degrees and diplomas of higher education
awarded by foreign higher education institutions)
8. Subsidy Month Stipend: 2.260,00 €/month according to the table of monthly maintenanceallowance amounts set out in Annex I of IGC Research Fellowship Regulation. The payment will
be made by bank transfer. The selected candidate will be reimbursed for the amountcorresponding to the Voluntary Social Security contribution.
9. Deadline for applications and how to submit applications: Interested candidates should send
their applications to igcpositions@igc.gulbenkian.pt in a single PDF file, named “Applicant
Name_ PostDoc_T cell acute lymphoblastic leukemia”, containing: Motivation Letter (2 pagemax); Curriculum Vitae (2 pages max), contact of at least two previous supervisors who canprovide reference letters upon request and proof of degree.
10. Methods of Selection and Evaluation: The selection procedure shall be as follows:
Curriculum (40%), motivation letter (20%), reference letters (20%). If considered necessary bythe jury, the interview of the selected applicants will represent (20%) of the final evaluation.
11. Jury Selection: Chairman: Dr. Vera Martins. Other members: Dr. Michelle Pereira and Dr.
Bruna Sabino Oliveira.
12. Form of Advertising / Notification of results: The assessment results will be sent to all
candidates by email. There will be 10 working days for complaints/appeals after the date ofpublication of the Selection Minute, through the same application email.
13. Application Period: From 09/05/2024 until 14/06/2024.
14. Non-discrimination and equal access policy: The Instituto Gulbenkian de Ciência of theCalouste Gulbenkian Foundation actively promotes a non-discrimination and equal access policy,
wherefore no candidate can be privileged, benefitted, impaired or deprived of any rights
whatsoever, or be exemptof any duties based on ancestry, age, sex, sexual preference, marital
status, family and economic conditions, education, origin or social conditions, genetic heritage,
reduced work capacity, disability, chronic illness, nationality, ethnic origin or race, origin
territory, language, religion, political or ideological convictions and union membership.

Financed by: